The Ion AmpliSeq RNA Lung Cancer Research Fusion Panel is based on an amplicon target enrichment approach that allows amplification and detection of 70 known fusion transcripts for the ALK, RET, ROS1, and NTRK1 genes using a couple of primers specific of each fusion (Fig. 1). The gene discussed is RET; the disease is lung cancer.